2210407C18Rik Activators
2210407C18Rik Activators encompass a range of chemical compounds that indirectly promote the functional activity of 2210407C18Rik through diverse signaling mechanisms. Forskolin, for instance, heightens intracellular cAMP levels, thereby indirectly facilitating the activity of 2210407C18Rik by enabling PKA to phosphorylate substrates that may interact with or modify the function of 2210407C18Rik. Similarly, IBMX preserves cAMP and cGMP within the cellular milieu, thereby potentiating pathways in which 2210407C18Rik acts. PMA, as an activator of Protein Kinase C, tailors signaling pathways that engage 2210407C18Rik, enhancing its activity through PKC-mediated phosphorylation events. A23187 leverages increased intracellular calcium to activate kinases or phosphatases that could target 2210407C18Rik or the network it operates within, while Sphingosine-1-phosphate initiates signaling through its receptors that might augment the role of 2210407C18Rik in cellular processes like proliferation.
Further, the PI3K inhibitor LY294002 can reconfigure the PI3K/Akt pathway, offering a potential indirect upregulation of 2210407C18Rik activity if involved in those signaling circuits. SB203580 and U0126, which target p38 MAPK and MEK1/2, respectively, modulate their specific pathways, potentially shifting the signaling equilibrium to favor processes that engage the function of 2210407C18Rik. Genistein and EGCG, by inhibiting tyrosine kinases and certain protein kinases, respectively, could also refine cellular signaling in a manner that promotes the function of 2210407C18Rik. Staurosporine, despite its broad kinase inhibition spectrum, might selectively enhance pathways that engage 2210407C18Rik by alleviating specific kinase-mediated suppression. Lastly, Thapsigargin, by disrupting calcium homeostasis, activates calcium-dependent signaling that could enhance the activity of 2210407C18Rik, illustrating the intricate web of intracellular signals that converge on the modulation of this protein's function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, thereby preventing the breakdown of cAMP and cGMP. By increasing these cyclic nucleotides within the cell, IBMX can indirectly enhance the functional activity of 2210407C18Rik through pathways that are regulated by cAMP/cGMP levels. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). By activating PKC, PMA can modulate signaling pathways that 2210407C18Rik may be a part of, thereby enhancing the functional activity of 2210407C18Rik through PKC-mediated signaling events. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which can activate calcium-dependent kinases and phosphatases. These enzymes could then modify the activity of 2210407C18Rik either by direct phosphorylation or by altering the regulatory network in which 2210407C18Rik operates. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates sphingosine-1-phosphate receptors, which can lead to downstream signaling events impacting cellular processes such as proliferation and survival. These processes could enhance the function of 2210407C18Rik by altering the signaling environment. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, which can alter signaling pathways downstream of PI3K including Akt signaling. By modulating these pathways, LY294002 could indirectly enhance the activity of 2210407C18Rik if it is involved in PI3K/Akt regulated processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. By inhibiting p38 MAPK, it can shift the balance of cellular signaling to pathways that may enhance the activity of 2210407C18Rik if it is involved in processes regulated by p38 MAPK. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may enhance the activity of 2210407C18Rik by reducing competitive phosphorylation events or by altering signaling cascades that intersect with tyrosine kinase pathways in which 2210407C18Rik might be involved. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to have inhibitory effects on certain protein kinases. By inhibiting these kinases, EGCG may promote signaling pathways that activate 2210407C18Rik or enhance its functional activity by altering the regulatory network. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, which might lead to selective activation of pathways where 2210407C18Rik is involved by reducing the overall kinase activity that could otherwise negatively regulate 2210407C18Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, leading to increased cytosolic calcium levels. This increase can activate calcium-dependent signaling pathways, potentially enhancing the functional activity of 2210407C18Rik through those pathways. | ||||||